carbonyl cyanide m-chlorophenyl hydrazone has been researched along with phalloidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christen, P; Jaussi, R; Skoda, RC | 1 |
Behm, T; Charney, AN; Dagher, PC; Egnor, RW; Taglietta-Kohlbrecher, A | 1 |
Duszyński, J; Szczepanowska, J; Zabłocki, K | 1 |
3 other study(ies) available for carbonyl cyanide m-chlorophenyl hydrazone and phalloidine
Article | Year |
---|---|
Vinblastine inhibits the maturation of the precursor of mitochondrial aspartate aminotransferase. Vincristine and six other cytoskeleton inhibitors do not show this effect.
Topics: Alkaloids; Animals; Aspartate Aminotransferases; Benzimidazoles; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Chick Embryo; Colchicine; Cytochalasin D; Cytochalasins; Enzyme Precursors; Fibroblasts; Kinetics; Mitochondria; Nocodazole; Oxygen Consumption; Paclitaxel; Phalloidine; Podophyllotoxin; Vinblastine | 1983 |
Dissociation of colonic apical Na/H exchange activity from bulk cytoplasmic pH.
Topics: Absorption; Animals; Biological Transport; Butyrates; Butyric Acid; Carbon Dioxide; Carbonic Anhydrases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Membrane; Colon; Cytoplasm; Fluoresceins; Fluorescent Dyes; Hydrogen; Hydrogen-Ion Concentration; Male; Phalloidine; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers | 1996 |
Influence of a mitochondrial genetic defect on capacitative calcium entry and mitochondrial organization in the osteosarcoma cells.
Topics: Actins; Ataxia; Benzimidazoles; Calcium; Carbocyanines; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Tumor; Cytoskeleton; DNA, Mitochondrial; Fluorescent Dyes; Fura-2; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ionophores; Membrane Potentials; Microscopy, Fluorescence; Mitochondrial Myopathies; Muscle Weakness; Mutation; Osteosarcoma; Phalloidine; Retinitis Pigmentosa; Rhodamines; Thapsigargin | 2004 |